An Automated Correction Algorithm (ALPACA) for ddPCR Data Using Adaptive Limit of Blank and Correction of False Positive Events Improves Specificity of Mutation Detection.
暂无分享,去创建一个
T. C. Linders | K. L. Ramkisoensing | G. Meijer | D. van den Broek | M. M. van den Heuvel | V. van der Noort | K. Monkhorst | D. Vessies | R. Schouten | M. Lanfermeijer | T. Linders | Kalpana L. Ramkisoensing
[1] H. Groen,et al. An All-In-One Transcriptome-Based Assay to Identify Therapy-Guiding Genomic Aberrations in Nonsmall Cell Lung Cancer Patients , 2020, Cancers.
[2] Jim F Huggett,et al. The Digital MIQE Guidelines Update: Minimum Information for Publication of Quantitative Digital PCR Experiments for 2020. , 2020, Clinical chemistry.
[3] J. A. Roldán-Nofuentes. Compbdt: an R program to compare two binary diagnostic tests subject to a paired design , 2020, BMC Medical Research Methodology.
[4] J. Barrett,et al. Optimisation of robust singleplex and multiplex droplet digital PCR assays for high confidence mutation detection in circulating tumour DNA , 2019, Scientific Reports.
[5] G. Romieu,et al. PIK3CA mutations early persistence in cell-free tumor DNA as a negative prognostic factor in metastatic breast cancer patients treated with hormonal therapy , 2019, Breast Cancer Research and Treatment.
[6] M. Guan,et al. Digital PCR-Based Detection of EGFR Mutations in Paired Plasma and CSF Samples of Lung Adenocarcinoma Patients with Central Nervous System Metastases , 2019, Targeted Oncology.
[7] Wei Liu,et al. Evaluation of EGFR mutations in NSCLC with highly sensitive droplet digital PCR assays , 2019, Molecular medicine reports.
[8] Jesse S. Voss,et al. Applying Standard Clinical Chemistry Assay Validation to Droplet Digital PCR Quantitative Liquid Biopsy Testing. , 2018, Clinical chemistry.
[9] S Senan,et al. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.
[10] P. Laurent-Puig,et al. Droplet-based digital PCR and next generation sequencing for monitoring circulating tumor DNA: a cancer diagnostic perspective , 2018, Expert review of molecular diagnostics.
[11] Ying Cheng,et al. EGFR T790M ctDNA testing platforms and their role as companion diagnostics: Correlation with clinical outcomes to EGFR-TKIs. , 2017, Cancer letters.
[12] Vladimir Potapov,et al. Examining Sources of Error in PCR by Single-Molecule Sequencing , 2017, PloS one.
[13] Y. Zhang,et al. Total DNA input is a crucial determinant of the sensitivity of plasma cell-free DNA EGFR mutation detection using droplet digital PCR , 2016, Oncotarget.
[14] N. Normanno,et al. Guide to detecting epidermal growth factor receptor (EGFR) mutations in ctDNA of patients with advanced non-small-cell lung cancer , 2016, Oncotarget.
[15] Suzanne E Dahlberg,et al. Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung Cancer. , 2016, JAMA oncology.
[16] Xianshu Gao,et al. "Liquid biopsy"-ctDNA detection with great potential and challenges. , 2015, Annals of translational medicine.
[17] D. Link,et al. Determining lower limits of detection of digital PCR assays for cancer-related gene mutations , 2014, Biomolecular detection and quantification.
[18] Masood Z. Hadi,et al. Error Rate Comparison during Polymerase Chain Reaction by DNA Polymerase , 2014, Molecular biology international.
[19] C. Paweletz,et al. Noninvasive Detection of Response and Resistance in EGFR-Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA , 2014, Clinical Cancer Research.
[20] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .